Concord Biotech Achieves 10.77% Increase in June 2024 Net Sales

Monday, 12 August 2024, 23:29

In June 2024, Concord Biotech reported standalone net sales of Rs 215.80 crore, reflecting a growth of 10.77% compared to Rs. 194.83 crore in June 2023. The company's quarterly net profit reached Rs. 58.24 crore during the same period. This positive trend indicates strong performance and market confidence for Concord Biotech moving forward.
Moneycontrol
Concord Biotech Achieves 10.77% Increase in June 2024 Net Sales

Concord Biotech's Standalone Financial Report

Concord Biotech has released its standalone quarterly financial figures for June 2024, showcasing a significant advancement.

Key Highlights

  • Net Sales: Rs 215.80 crore
  • Year-on-Year Growth: 10.77%
  • Previous Year Sales: Rs 194.83 crore
  • Quarterly Net Profit: Rs 58.24 crore

This growth demonstrates the company's strong market performance and financial health.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most reliable and up-to-date tech news. Stay informed and elevate your tech expertise effortlessly.

Subscribe